Ibandronate Sodium Tablet
Product Images NDC 55111-575

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 55111-575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blistercard (Blistercard)

Ibandronate sodium 150 mg oral tablet label by Dr. Reddy's Laboratories Limited. The label includes the proprietary and generic name, dosage strength, route of administration, and manufacturer details with instructions to push the tablet through the packaging. The design features green embossing area markers and repeated product information.*

FDA Label Image

Carton

Packaging label for Ibandronate Sodium Tablet 150 mg oral tablets by Dr. Reddy's Laboratories Limited. The label indicates a three-month supply pack containing three 150 mg tablets for once-monthly osteoporosis therapy. The label includes dosage instructions, storage conditions, and a note for the pharmacist to dispense with the medication guide. The packaging displays the product NDC 55111-575 and contains barcode and manufacturer details.*

FDA Label Image

Innercarton (Innercarton)

Packaging label for Ibandronate Sodium Tablet, 150 mg, an oral tablet by Dr. Reddy's Laboratories Limited. The label indicates a once-monthly dose for osteoporosis therapy. It includes usage instructions, dosage information, storage conditions, and a barcode. The label also highlights that this is a human prescription drug with a single tablet per pack.*

FDA Label Image

Outercarton (Outercarton)

The image shows the packaging label for Ibandronate Sodium Tablets 150 mg oral tablets, labeled as once-monthly. The package contains 3 packs with one tablet per pack. It is manufactured by Dr. Reddy's Laboratories Limited in India. The label includes directions to dispense the product with a medication guide and displays the product NDC 55111-575-03 along with a barcode and QR code linking to the medication guide.*

FDA Label Image

Pouch (Pouch)

Packaging label for Ibandronate Sodium Tablet, 150 mg, oral tablet by Dr. Reddy's Laboratories Limited. The label states the strength, dosage form, and manufacturer. It highlights the product as a once-monthly osteoporosis therapy containing 150 mg of ibandronate sodium. Instructions to open the package and a caution to not remove the pill from the foil until ready for use are included.*

FDA Label Image

Structure (Structure)

Chemical structure of Ibandronate sodium showing detailed molecular components and their bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.